TRPC6 and early-onset autosomal dominant Alzheimer disease: Previously, an inhibitory effect of presenilin 2 and its Alzheimer’s-disease-linked variants on receptor-operated TRPC6 function has been demonstrated in heterologous expression systems, suggesting functional interaction between presenilins and TRPC6 (Lessard et al., 2005).